m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00596)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
TRAF6
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | mouse embryonic stem cells | Mus musculus |
Treatment: METTL3-/- ESCs
Control: Wild type ESCs
|
GSE145309 | |
Regulation |
|
logFC: 1.02E+00 p-value: 2.31E-81 |
More Results | Click to View More RNA-seq Results | |
Representative RIP-seq result supporting the interaction between TRAF6 and the regulator | ||
Cell Line | MDA-MB-231 | Homo sapiens |
Regulation | logFC: 1.04E+00 | GSE60213 |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | METTL3 is highly expressed in OS and enhances TNF receptor-associated factor 6 (TRAF6) expression through m6A modification, thereby promoting the metastases of OS cells. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Osteosarcoma | ICD-11: 2B51 | ||
In-vitro Model | U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 |
SaOS-2 | Osteosarcoma | Homo sapiens | CVCL_0548 | |
NHOst (Normal human osteoblast cells) | ||||
MG-63 | Osteosarcoma | Homo sapiens | CVCL_0426 | |
HOS | Osteosarcoma | Homo sapiens | CVCL_0312 | |
In-vivo Model | For mouse xenograft tumor model, 1×106 Saos2 or HOS cells were mixed in 200 ul PBS and injected subcutaneously into 6- to 8-week-old C57BL/6 mice.umor size of mice was measured by vernier calipers every week after injection. The mice were euthanized after 28 days by intraperitoneal injection of 1% pentobarbital sodium (120 mg/kg), and the tumor tissues were removed from the mice. | |||
Osteosarcoma [ICD-11: 2B51]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | METTL3 is highly expressed in OS and enhances TNF receptor-associated factor 6 (TRAF6) expression through m6A modification, thereby promoting the metastases of OS cells. | |||
Responsed Disease | Osteosarcoma [ICD-11: 2B51] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
In-vitro Model | U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 |
SaOS-2 | Osteosarcoma | Homo sapiens | CVCL_0548 | |
NHOst (Normal human osteoblast cells) | ||||
MG-63 | Osteosarcoma | Homo sapiens | CVCL_0426 | |
HOS | Osteosarcoma | Homo sapiens | CVCL_0312 | |
In-vivo Model | For mouse xenograft tumor model, 1×106 Saos2 or HOS cells were mixed in 200 ul PBS and injected subcutaneously into 6- to 8-week-old C57BL/6 mice.umor size of mice was measured by vernier calipers every week after injection. The mice were euthanized after 28 days by intraperitoneal injection of 1% pentobarbital sodium (120 mg/kg), and the tumor tissues were removed from the mice. | |||